Total equity of $18.5B against total liabilities of $53.6B in 2026Q3 implies a debt-to-equity ratio of 0.24 and an equity-to-assets ratio near 26%, suggesting a reasonable capital cushion that remains sensitive to investment valuations.
Markel Corporation (MKL) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Assets | 72.08B | 68.91B | 47.35B | 43.44B | 49.79B | 48.48B | 34.27B | 30.63B | 27.2B | 27.39B | 24.16B | 23.24B | 23.58B | 22.28B | 11.95B | 11.01B | 10.22B | 10.24B | 9.48B | 10.13B | 10.09B | 9.81B | 9.4B | 8.53B | 7.41B | 6.44B | 5.47B | 2.46B | 1.92B | 1.87B | 1.61B |
| Asset Growth % | 172.87% | 45.54% | 8.98% | -12.75% | 2.71% | 41.46% | 11.9% | 12.58% | -0.7% | 13.37% | 3.99% | -1.46% | 5.82% | 86.45% | 8.6% | 7.7% | -0.23% | 8.06% | -6.48% | 0.46% | 2.79% | 4.43% | 10.14% | 15.17% | 15.03% | 17.68% | 122.91% | 27.79% | 2.74% | 16.5% | 22.12% |
| Total Investment Assets | 4M | 32.84B | 30.92B | 27.13B | 22.2B | 23.41B | 19.71B | 18.76B | 16.84B | 18.07B | 16.97B | 15.11B | 16.16B | 14.85B | 8.36B | 7.95B | 7.48B | 7B | 6.27B | 7.31B | 6.98B | 0 | 243.43M | 4.98B | 3.87B | 3.29B | 2.89B | 1.62B | 0 | 0 | 0 |
| Long-Term Investments | 82.03B | 25.77B | 30.92B | 27.13B | 7.67B | 9.02B | 19.71B | 18.76B | 16.84B | 18.07B | 16.97B | 15.11B | 16.16B | 14.85B | 8.36B | 7.95B | 7.48B | 7B | 6.27B | 7.31B | 6.98B | 0 | 121.71M | 4.98B | 3.87B | 3.29B | 2.89B | 1.62B | 0 | 0 | 0 |
| Short-Term Investments | 33.17B | 7.07B | 0 | 0 | 14.53B | 14.39B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 121.71M | 82.01M | 67.82M | 64.79M | 80.71M | 141.75M | 0 | 0 | 0 |
| Total Current Assets | 63.02B | 33.32B | 7.06B | 6.96B | 33.22B | 30.77B | 7.15B | 4.93B | 3.72B | 3.82B | 3.15B | 4.08B | 3.51B | 3.82B | 1.31B | 1.06B | 1B | 2B | 1.91B | 1.83B | 2.12B | 2.96B | 2.84B | 905.44M | 920.6M | 2.17B | 1.66B | 664.11M | 0 | 0 | 0 |
| Cash & Equivalents | 3.6B | 3.96B | 4.19B | 4.33B | 4.14B | 3.98B | 5.22B | 3.5B | 2.4B | 2.5B | 2.09B | 3.07B | 2.48B | 2.77B | 973.18M | 775.03M | 745.26M | 850.49M | 639.58M | 477.66M | 555.12M | 333.76M | 378.94M | 372.51M | 444.24M | 296.78M | 250.32M | 1.81M | 0 | 0 | 0 |
| Receivables | 63.11B | 18.58B | 2.87B | 2.63B | 11.41B | 9.71B | 1.93B | 1.42B | 1.33B | 1.32B | 1.06B | 1.01B | 1.03B | 1.06B | 332.57M | 283.25M | 257.03M | 1.15B | 1.27B | 1.36B | 1.57B | 0 | 0 | 450.92M | 408.54M | 1.81B | 1.33B | 520.55M | 287.63M | 0 | 0 |
| Other Current Assets | 594.14M | 638.6M | 0 | 0 | 1.08B | 902.46M | 9.6B | 6.88B | 5.59B | 6.58B | 6.46B | 6.31B | 5.97B | 6.25B | 2.66B | 1.97B | 1.59B | 2.64B | 2.6B | 2.09B | 2.5B | 2.96B | 2.84B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 19.02B | 5.27B | 4.2B | 4.21B | 5.31B | 5.52B | 4.39B | 4.05B | 3.96B | 3.13B | 1.86B | 1.96B | 1.75B | 1.53B | 1.05B | 867.56M | 645.9M | 502.83M | 344.03M | 344.91M | 339.72M | 339.72M | 339.72M | 357.32M | 361.44M | 372.13M | 403M | 92.31M | 35.3M | 37.3M | 39.3M |
| Goodwill | 2.84B | 2.82B | 2.74B | 2.62B | 2.64B | 2.9B | 2.6B | 2.31B | 2.24B | 1.78B | 1.14B | 1.17B | 1.05B | 967.72M | 674.93M | 0 | 0 | 0 | 0 | 0 | 339.72M | 339.72M | 339.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.43B | 2.45B | 1.46B | 1.59B | 2.67B | 2.62B | 1.78B | 1.74B | 1.73B | 1.36B | 722.54M | 792.37M | 702.75M | 565.08M | 374.3M | 867.56M | 645.9M | 502.83M | 344.03M | 344.91M | 0 | 0 | 0 | 357.32M | 361.44M | 372.13M | 403M | 92.31M | 35.3M | 37.3M | 39.3M |
| PP&E (Net) | 0 | 0 | 2.08B | 1.93B | 0 | 0 | 1.16B | 821.32M | 551.54M | 501.62M | 412.4M | 430.83M | 421.39M | 347.91M | 330.23M | 244.85M | 159.57M | 100.24M | 57.26M | 50.53M | 45.97M | 49.54M | 30.22M | 0 | 0 | 0 | 0 | 9.9M | 8M | 10.1M | 15.4M |
| Other Assets | 4.79B | 4.54B | 3.05B | 3.19B | 3.59B | 3.16B | 1.86B | 2.05B | 1.67B | 1.43B | 1.11B | 970.61M | 1.02B | 961.01M | 571.57M | 481.92M | 527.08M | 476.7M | 525.91M | 514.54M | 560.78M | -523.38M | 6.02B | -4.98B | -3.87B | -3.67B | -3.29B | -1.73B | -43.3M | -47.4M | -54.7M |
| Total Liabilities | 53.57B | 49.8B | 29.88B | 27.92B | 36.05B | 33.28B | 21.21B | 19.37B | 17.93B | 17.73B | 15.62B | 15.33B | 15.92B | 15.53B | 7.98B | 7.54B | 7.03B | 7.45B | 7.3B | 7.49B | 7.79B | 8.11B | 7.74B | 7.15B | 6.25B | 5.21B | 4.57B | 167.98M | 93.2M | 93.2M | 114.7M |
| Total Debt | 4.36B | 4.3B | 5.65B | 4.97B | 4.1B | 4.82B | 4.52B | 4.01B | 3.01B | 3.1B | 2.57B | 2.24B | 2.25B | 2.26B | 1.49B | 1.29B | 1.02B | 963.65M | 688.51M | 680.7M | 858.36M | 848.88M | 855.08M | 762.11M | 490.49M | 381.02M | 573.11M | 167.98M | 93.2M | 93.2M | 114.7M |
| Net Debt | 758.26M | 339.11M | 1.45B | 636.35M | -33.8M | 844.15M | -692.44M | 508.58M | 613.14M | 598.38M | 489.37M | -828.71M | -228.8M | -509.23M | 519.37M | 518.49M | 270.69M | 113.15M | 48.93M | 203.04M | 303.24M | 515.12M | 476.14M | 389.6M | 46.26M | 84.24M | 322.79M | 166.17M | 93.2M | 93.2M | 114.7M |
| Long-Term Debt | 4.36B | 4.3B | 4.88B | 4.24B | 3.85B | 4.82B | 3.92B | 3.68B | 2.72B | 3.01B | 2.39B | 2.21B | 2.23B | 2.23B | 1.25B | 1.05B | 769.86M | 962.91M | 688.51M | 587.65M | 678.95M | 749.99M | 855.08M | 762.11M | 640.49M | 381.02M | 573.11M | 167.98M | 93.2M | 93.2M | 114.7M |
| Short-Term Debt | 0 | 0 | 172.79M | 202M | 249.94M | 0 | 126.8M | 113.05M | 288.54M | 86.31M | 183.92M | 30.27M | 23.34M | 28.8M | 246.62M | 246.35M | 246.08M | 733K | 0 | 93.05M | 179.41M | 98.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 43.04B | 39.78B | 0 | 0 | 28.09B | 24.18B | 0 | 0 | 5.4B | 4.94B | 2.24B | 2.24B | 2.14B | 2.15B | 881.99M | 64.33M | 50.72M | 1.01B | 42.4M | 0 | 0 | 0 | 0 | 0 | 0 | 4.83B | 4B | 0 | 0 | 0 | 0 |
| Accounts Payable | 0 | 1.67B | 1.43B | 1.04B | 669.74M | 7.49B | 6.23B | 5.66B | 5.4B | 4.94B | 2.24B | 2.24B | 2.14B | 2.15B | 881.99M | 855.43M | 50.72M | 46.85M | 42.4M | 39.79M | 0 | 0 | 89.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 7.43B | 7.25B | 7.06B | 6.64B | 6.22B | 5.38B | 2.98B | 2.64B | 0 | 0 | 1.96B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.01B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 33.86B | 30.86B | -8.67B | -7.88B | 20.95B | 11.3B | -9.34B | -8.42B | -5.69B | -5.03B | -4.39B | -2.27B | -23.34M | -28.8M | -246.62M | -1.04B | -246.08M | -733K | 0 | -93.05M | -1.25B | 5.88B | 5.48B | -150.16M | -122.19M | 4.66B | 3.86B | -60.71M | -22.71M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.18B | 5.72B | 22.8B | 21.95B | 4.11B | 4.27B | 15.82B | 14.59B | 14.31B | 13.77B | 12.24B | 12.26B | 12.66B | 12.64B | 6.23B | 6.09B | 5.92B | 6.49B | 6.61B | 6.91B | 7.11B | -749.99M | 1.31B | -762.11M | -640.49M | -381.02M | -573.11M | -167.98M | -93.2M | -93.2M | -114.7M |
| Total Equity | 18.51B | 19.1B | 17.47B | 15.53B | 13.74B | 15.2B | 13.06B | 11.26B | 9.27B | 9.67B | 8.54B | 7.9B | 7.66B | 6.75B | 3.98B | 3.46B | 3.19B | 2.79B | 2.18B | 2.64B | 2.3B | 1.71B | 1.66B | 1.38B | 1.16B | 1.24B | 902.37M | 533.42M | 575.3M | 506.8M | 268.3M |
| Equity Growth % | 20.33% | 9.35% | 12.52% | 13.02% | -9.63% | 16.4% | 16.03% | 21.37% | -4.07% | 13.19% | 8.07% | 3.14% | 13.52% | 69.81% | 14.81% | 8.62% | 14.18% | 28.02% | -17.44% | 15.01% | 34.65% | 2.95% | 19.84% | 19.25% | -6.15% | 36.87% | 69.17% | -7.28% | 13.52% | 88.89% | 25.73% |
| Shareholders Equity | 18.51B | 18.6B | 16.92B | 14.98B | 13.15B | 14.72B | 12.8B | 11.07B | 9.08B | 9.5B | 8.46B | 7.83B | 7.59B | 6.67B | 3.89B | 3.39B | 3.17B | 2.77B | 2.18B | 2.64B | 2.3B | 1.71B | 1.66B | 1.38B | 1.16B | 1.09B | 752.37M | 383.42M | 425.3M | 356.8M | 268.3M |
| Minority Interest | -1.64M | 504.43M | 553.08M | 541.97M | 585.95M | 484.24M | 260.53M | 185.11M | 193.71M | 163.7M | 80.16M | 69.42M | 68.23M | 76.62M | 86.58M | 74.83M | 16.17M | 17.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 150M | 150M | 150M | 150M | 150M | 0 |
| Retained Earnings | 15.51B | 15.03B | 13.38B | 11.35B | 9.83B | 10.45B | 8.2B | 7.46B | 5.78B | 3.78B | 3.53B | 3.14B | 2.58B | 2.29B | 2.07B | 1.84B | 1.74B | 1.51B | 1.3B | 1.42B | 1.02B | 669.06M | 537.07M | 375.04M | 251.57M | 176.25M | 302M | 342.43M | 303.9M | 246.9M | 200.2M |
| Common Stock | 3.72B | 3.67B | 3.56B | 3.52B | 3.49B | 3.44B | 3.43B | 3.4B | 3.39B | 3.38B | 3.37B | 3.34B | 3.31B | 3.29B | 908.98M | 891.51M | 884.46M | 872.88M | 869.74M | 866.36M | 854.56M | 743.5M | 742.29M | 737.36M | 736.25M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -720.7M | -109.46M | -617.08M | -478.21M | -767.49M | 237.62M | 584.38M | 208.77M | -94.65M | 2.35B | 1.57B | 1.35B | 1.7B | 1.09B | 911.34M | 660.92M | 551.09M | 387.09M | 13.03M | 357.53M | 426.15M | 292.87M | 377.15M | 269.88M | 171.3M | 173.29M | 124.46M | 15.37M | 0 | 0 | 0 |
| Return on Equity (ROE) | 9.53% | 11.52% | 16.65% | 13.64% | -1.49% | 17.15% | 6.71% | 17.44% | -1.35% | 4.34% | 5.54% | 7.49% | 4.46% | 5.24% | 6.81% | 4.27% | 8.92% | 8.11% | -2.44% | 16.43% | 19.62% | 8.8% | 10.89% | 9.72% | 6.29% | -11.76% | -3.84% | 7.33% | 10.59% | 13% | 19.39% |
| Return on Assets (ROA) | 2.55% | 3.62% | 6.05% | 4.28% | -0.44% | 5.86% | 2.51% | 6.19% | -0.47% | 1.53% | 1.92% | 2.49% | 1.4% | 1.64% | 2.21% | 1.34% | 2.61% | 2.05% | -0.6% | 4.01% | 3.94% | 1.54% | 1.85% | 1.55% | 1.09% | -2.11% | -0.7% | 1.86% | 3.02% | 2.9% | 3.2% |
| Equity / Assets | 25.67% | 27.72% | 36.9% | 35.74% | 27.59% | 31.36% | 38.11% | 36.75% | 34.09% | 35.29% | 35.35% | 34.01% | 32.5% | 30.29% | 33.26% | 31.46% | 31.2% | 27.26% | 23.01% | 26.06% | 22.76% | 17.38% | 17.63% | 16.2% | 15.65% | 19.18% | 16.49% | 21.73% | 29.94% | 27.1% | 16.71% |
| Debt / Equity | 0.24x | 0.23x | 0.32x | 0.32x | 0.30x | 0.32x | 0.35x | 0.36x | 0.32x | 0.32x | 0.30x | 0.28x | 0.29x | 0.33x | 0.38x | 0.37x | 0.32x | 0.35x | 0.32x | 0.26x | 0.37x | 0.50x | 0.52x | 0.55x | 0.42x | 0.31x | 0.64x | 0.31x | 0.16x | 0.18x | 0.43x |
| Book Value per Share | 1486.76 | 1500.56 | 1339.54 | 1160.55 | 1011.56 | 1101.56 | 944.83 | 810.89 | 666.12 | 690.26 | 606.70 | 562.09 | 545.14 | 536.33 | 407.27 | 355.99 | 325.83 | 284.12 | 222.20 | 264.62 | 230.52 | 170.64 | 164.34 | 137.81 | 117.72 | 144.72 | 130.49 | 94.56 | 102.12 | 89.70 | 47.68 |
| Tangible BV per Share | 1144.43 | 1086.22 | 1017.83 | 845.60 | 620.42 | 701.87 | 627.43 | 519.34 | 381.40 | 466.56 | 474.24 | 422.68 | 420.52 | 414.54 | 299.78 | 266.79 | 259.81 | 232.94 | 187.15 | 230.06 | 196.41 | 136.65 | 130.63 | 102.18 | 81.01 | 101.11 | 72.21 | 78.20 | 95.85 | 83.09 | 40.70 |
Quick answers to the most common questions about buying MKL stock.
As of 2025, Markel Corporation (MKL) had total assets of $68.91B including $33.32B in current assets.
Markel Corporation (MKL) carries total debt of $4.30B, offset by $11.03B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Markel Corporation (MKL) has total shareholders' equity (book value) of $18.60B ($1500.56 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Markel Corporation (MKL) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Social inflation casualty reserve pressure
Metrics are mathematically derived from official filings.
Equity Base Growing Amid Volatility
Based on Markel's reported quarterly figures, total equity rose from roughly $15.9B in 2024Q2 to about $19.0B in 2026Q2, though the 2026Q1 dip to $18.1B shows that book value growth has been uneven and partly dependent on mark-to-market swings.
The equity base has expanded more than total liabilities over the window, which suggests retained earnings and capital generation are still outpacing claims-driven balance sheet pressure. However, the quarter-to-quarter volatility in equity indicates that a meaningful share of the change reflects investment valuation movements rather than steady underwriting capital creation. Investors should monitor whether equity growth persists once the equity portfolio's unrealized gains normalize.
Reserve Ratios Hinge on Casualty Development
Based on reported figures, quarterly loss ratios ranged from roughly 30% to 55% over the last ten quarters, and the lower prints may partly reflect favorable prior-year reserve development that could reverse if US casualty trends deteriorate.
Total liabilities expanded from about $29.9B to $53.6B in the reported window, and the reserve base is therefore the largest and most sensitive balance sheet item. The sharp drop in loss ratio during several quarters is consistent with reserve releases, which may flatter current earnings while leaving social inflation exposure under-recognized. This warrants further investigation into the adequacy of long-tail casualty reserves.
Investment Portfolio Drives Earnings Swings
As reported in quarterly income statements, net income swung from a loss in 2026Q1 to strong gains in other periods, with EPS ranging from -18.90 to 92.76, indicating that equity mark-to-market movements dominate reported profitability.
Because a large equity holding is marked through the income statement, headline earnings are a poor proxy for underlying underwriting performance. Operating income of negative $273.3M in 2026Q1 contrasts sharply with the strong 2026Q2 result, suggesting that the investment portfolio is the principal source of volatility. Analysts should separate operating earnings from valuation effects when assessing capital capacity.
Capital Base Adequate but Market-Sensitive
Based on Markel's reported equity of roughly $18.5B against total assets of $72.1B in 2026Q3, the equity-to-assets ratio of about 26% suggests a reasonable capital cushion, though its sensitivity to investment valuations warrants monitoring.
Statutory capital adequacy data such as RBC ratios are not provided in the supplied dataset, so this assessment relies on book equity alone and should be treated as directional. The capital base is large relative to the premium base, which may provide room for buybacks and acquisitions. However, a significant equity market drawdown could compress book value quickly given the portfolio's concentration.
Earnings Quality May Overstate Balance Sheet Strength
The strongest challenge to the balance sheet read is that quarterly combined ratios above 100% in 2026Q1 and sharp swings in equity suggest reported strength may rely on favorable loss ratios and investment gains that could prove temporary.
If reserve releases and equity gains are masking underlying underwriting weakness, the apparent adequacy of the balance sheet could erode faster than headline figures imply. Investors should monitor whether the combined ratio stabilizes below 100% without reserve support. This is an analytical inference from reported figures rather than a confirmed deterioration.